The FDA is scheduled to announce these two key approval decisions in late November.
Compare BMY Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Bristol Myers Squibb
News & Analysis: Bristol Myers Squibb
These two biotech stocks trade at reasonable valuations and will turbocharge your income portfolio.
Big-time bargains are available for opportunistic long-term investors.
Short-term volatility can be a patient, long-term investor's best friend.
Maybe, but not if you're looking for major growth over the short term.
Don't miss out on these two thriving businesses.
Berkshire Hathaway's stakes in these top-tier companies were reduced during the second quarter.
You can expect your dividend income to rise over the years with these impressive companies.
They may not remain cheap for much longer.
The stocks come pre-vetted by the best in the business.